Multimodal gnaq signaling: precision therapy for metastatic uveal melanoma prevention and treatment
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110821
- Recipient
-
University Of California, San Diego UEI UYTTZT6G9DT1
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $632,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- La Jolla, CA 92093, USA
Award details come from USAspending.gov.
About this award
The University of California, San Diego will use a $632,000 Project Grant from the Department of the Army Medical Command to support research titled "MULTIMODAL GNAQ SIGNALING: PRECISION THERAPY FOR METASTATIC UVEAL MELANOMA PREVENTION AND TREATMENT." The grant is part of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health through innovative biomedical research solutions for battlefield medicine. Under this three-year award beginning September 1, 2021, UC San Diego researchers will investigate medical solutions for metastatic uveal melanoma, the most common primary eye tumor in adults, with the goal of developing precision therapies to prevent and treat this form of cancer. The place of performance for this research is La Jolla, California.
Quick answers
Who received award W81XWH2110821?
W81XWH2110821 was awarded to University Of California, San Diego by Medical Command (Department of the Army) on September 1, 2021.
How much is award W81XWH2110821 worth?
$632,000 has been obligated on W81XWH2110821.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award